BNTX - BioNTech SE
98.39
-6.960 -7.074%
Share volume: 1,009,157
Last Updated: 03-11-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.00%
PREVIOUS CLOSE
CHG
CHG%
$105.35
-6.96
-0.07%
Summary score
21%
Profitability
32%
Dept financing
4%
Liquidity
75%
Performance
0%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
14.29%
Return on assets
13.62%
Return on sales
-6.59%
Return on invested capital
-56.74%
Total debt ratio
22.02%
Debt ratio change over timeo
-1.22%
Current Ratio
6.65%
Quick Ratio
6.5%
Cash Position Ratio
3.65%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0.15%
Return on assets
-0.42%
Return on sales
-132.4%
Return on invested capital
3.44%
Total debt ratio
10.81%
Debt ratio change over timeo
-1.04%
Current Ratio
10.44%
Quick Ratio
10.22%
Cash Position Ratio
6.62%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-1.58%
Return on assets
-2.3%
Return on sales
-272.71%
Return on invested capital
-13.26%
Total debt ratio
10.28%
Debt ratio change over time
-0.69%
Current Ratio
11.38%
Quick Ratio
11.16%
Cash Position Ratio
5.59%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-113.85%
Return on assets
-113.84%
Return on sales
-46.04%
Return on invested capital
-54.65%
Total debt ratio
-122.13%
Debt ratio change over time
-1.22%
Current Ratio
-3.51%
Quick Ratio
-3.46%
Cash Position Ratio
-1.99%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
Long-term ratios | BNTX | AMGN | GILD | BIIB |
---|---|---|---|---|
Return on equity | 14.29% | 18.15% | 2.92% | 4.58% |
Return on assets | 13.62% | 3.24% | 3.24% | 2.5% |
Return on sales | -6.59% | 32.46% | 30.87% | 24.31% |
Return on invested capital | -56.74% | 5.53% | 1.1% | 4.42% |
Profitability | 45% | 81% | 39% | 50% |
Total debt ratio | 22.02% | 90.54% | 68.15% | 49.25% |
Debt ratio change over time | -1.22% | 17.23% | 106.35% | 3.43% |
Dept financing | 6% | 29% | 44% | 14% |
Current Ratio | 10.44% | 2.18% | 1.19% | 2.26% |
Quick Ratio | 10.22% | 1.79% | 1.05% | 1.63% |
Cash Position Ratio | 6.62% | 1.28% | 0.5% | 0.61% |
Liquididy | 75% | 20% | 16% | 22% |
Short-term ratios | BNTX | AMGN | GILD | BIIB |
---|---|---|---|---|
Return on equity | 0.15% | 0% | -0.7% | 1.97% |
Return on assets | -0.42% | 2.04% | 1.42% | 1.68% |
Return on sales | -132.4% | 24.13% | 12.88% | 18.45% |
Return on invested capital | 3.44% | 0% | -0.19% | 2.14% |
Profitability | 27% | 50% | 31% | 80% |
Total debt ratio | 10.81% | 93.05% | 66.24% | 44.68% |
Debt ratio change over time | -1.04% | 0% | 11.15% | -12.97% |
Dept financing | 3% | 25% | 43% | 12% |
Current Ratio | 10.44% | 2.18% | 1.19% | 2.26% |
Quick Ratio | 10.22% | 1.79% | 1.05% | 1.63% |
Cash Position Ratio | 6.62% | 1.28% | 0.5% | 0.61% |
Liquididy | 75% | 14% | 7% | 12% |